Connect with us
Anglostratits

Health

Breast Cancer Cost Seven African Economies Over $10 Billion in Lost Productivity, New Analysis Shows

Published

on

Cancer

The research also showed how every dollar invested in innovative cancer treatments can generate up to USD12.40 in economic returns, primarily by restoring women’s productivity

NAIROBI, Kenya, March 11, 2026/APO Group/ —

  • Findings were presented at the 2026 Roche Africa Press Day in Nairobi (https://www.Roche.com), which convened journalists from nine African countries with policymakers and health experts
  • The event focused on the theme “Health is Wealth,” exploring how investment in women’s health can drive economic growth and stronger health system
  • Research reveals every dollar invested in innovative breast cancer treatments generates up to USD 12.40 in economic return

 

Investing strategically in the health of Africa’s women will unlock billions of dollars in economic growth, as well as saving lives and strengthening communities, according to speakers at Africa Press Day held in Nairobi on March 4-5.

Convened by healthcare company Roche, the 2026 edition of Africa Press Day gathered journalists from nine African countries, alongside policymakers, economists, health experts, and development finance leaders. They discussed evidence and case studies proving how public private partnerships and strategic investments in health systems, especially in women’s health, can build human capital, productive workforces, and resilient economies.

In a keynote address, Kenya’s Principal Secretary State Department for Medical Services, Ministry of Health, Dr Ouma Oluga, urged media to help shape an informed narrative about improving health: “When a health story is being told, what is most important to portray? Is it what is killing people? Is it the solutions that should stop what is killing people? Or is it the in-between—the administrative, resource, and policy actions that link the two?”

As African governments increasingly focus on economic diversification and productivity, speakers argued that health investment must be treated as core economic policy — not simply a social expenditure.

Health is Wealth: The Economic Case for Investment 

Kenya’s EMPOWER initiative highlights how partnership and digital innovation can create a step-change in women’s healthcare

To demonstrate the returns on investing in women’s health, Roche unveiled research (http://apo-opa.co/4b2mjzX) from the WifOR Institute showing how the aggressive form of HER2+ breast cancer (responsible for up to 20% of cases on the continent) caused over USD10 billion in lost productivity across seven African countries (Algeria, Côte d’Ivoire, Kenya, Morocco, Nigeria, South Africa, and Tunisia) from 2017-2023.

Nearly 90% of these losses came from women in their prime working years. The research also showed how every dollar invested in innovative cancer treatments can generate up to USD12.40 in economic returns, primarily by restoring women’s productivity and allowing for longer healthy working lives.

Maturin Tchoumi, Pharma International Area Head, Roche Africa, said: “Breast cancer is a rising threat to African societies and economies. The evidence clearly shows that investing in women’s health is not a cost or a social expense, but a powerful economic driver that underpins productivity, resilience, equity, and sustainable growth across the continent.”

Health Is Equity: Closing the Diagnosis Gap

Extending quality cancer care to all African women, regardless of geography or income, was a key theme of the event. This included closing the gaps in breast cancer screening and early diagnosis that lead to around 77 per cent (http://apo-opa.co/4cFcF7F) of African women being diagnosed in the later stages of the disease when it is much harder – and more expensive – to treat.

H.E. Dorothy Nyong’o, First Lady of Kisumu County, Chair of the Africa Cancer Foundation, and member of the Africa Breast Cancer Council, highlighted Kenya’s EMPOWER (http://apo-opa.co/4s7GuCH) initiative for breast and cervical cancer (which delegates visited at a local hospital). It has digitised the patient journey via 76 physical and virtual clinics, speeding up diagnosis and treatment. Since its founding in 2019, EMPOWER has reached over 235,000 women, enabling 3,225 to receive treatment, and been adopted by the National Cancer Institute of Kenya as a nationally integrated platform.

H.E. Dorothy Nyong’o said: “Tackling breast cancer is not just a moral issue; it’s a strategic choice. Kenya’s EMPOWER initiative highlights how partnership and digital innovation can create a step-change in women’s healthcare. It offers a blueprint to other African countries for public-private collaboration that drives systemic, equitable, and lasting change.”

Health is Resilience: Strengthening African Health systems

Throughout the 2026 Africa Press Day, speakers shared details of initiatives that are working to strengthen health systems, including:

  • Women’s Integrated Care Services (WICs) in Kenya and Côte d’Ivoire, pilot projects that integrate women’s cancer services into primary health care for greater efficiency.
  • Home grown pandemic preparedness efforts, including sustainable and integrated diagnostic facilities and laboratory networks.
  • African-led science – including genomics and local research – that is contributing to African health sovereignty.

Distributed by APO Group on behalf of Roche.

 

Health

Water constraints become a defining economic and infrastructure risk

Published

on

health

The volume examines water security through operational, environmental and financial lenses

CAPE TOWN, South Africa, October 7, 2026/APO Group/ –Water resources, when left unchecked, are a constraint on economic growth, public health and social stability. For utilities, municipalities, industry and investors, the implications extend beyond resource availability to infrastructure performance, revenue, financing and long-term operational continuity.
 




 
These issues are examined in ESI Africa’s Water Security & Infrastructure Industry Insights Volume, published in partnership with Conlog and the STS Association. ESI Africa, a long-standing media brand within VUKA Group, brings together analysis of the pressures changing how water is managed, financed and valued.

Download the Water Security & Infrastructure Volume (https://apo-opa.co/4dr8xYs)

From water crisis to system risk

The volume examines water security through operational, environmental and financial lenses. Its content considers whether the hydrological chain is breaking, how intensive water users are exposed to risk and how demand from data centres is adding another dimension to competition for available resources.

It also addresses:

  • the connection between non-revenue water and blended finance,
  • the influence of tariff politics on water security, and
  • the role metering can play in improving how existing supplies are managed.

Together, these subjects point to a central industry concern. New supply and large infrastructure projects remain necessary, but stronger management of existing resources, networks and revenue is equally significant.

The volume’s argument is grounded in the principle that the smartest litre may be the one already available within the system.

Technology must support service outcomes

Smart infrastructure can improve visibility, measurement and operational decision-making, but technology must be linked to service delivery and climate resilience.

The ESI Africa webinar Smart infrastructure for climate resilient water service develops this theme by considering how infrastructure and digital capabilities can support more robust water services.

Watch Smart infrastructure for climate resilient water service (https://apo-opa.co/4jHVVjs)

Agro-industrial futures: Scaling alternative water solutions in agriculture examines alternative approaches for a sector in which water availability is closely linked to production and food security.

Watch Agro-industrial futures on-demand (https://apo-opa.co/4hK0F5r)

Water resilience for private sector business: The business case for water security considers why organisations need to treat water as an operational and commercial concern.

Watch the business case for water security (https://apo-opa.co/4j3VUGn)

Taking the discussion from analysis to implementation

Water Security Africa provides an in-person continuation of the discussion. The Johannesburg platform focuses on industrial water resilience, while Water Security Africa at Enlit Africa brings water and energy stakeholders together at the CTICC in Cape Town from 11 to 13 May 2027.

Explore Water Security Africa (https://apo-opa.co/4hQiDDv)

Projects will also play a central role in improving water security. The Project & Investment Network, in partnership with the African Infrastructure Elites: Projects and People annual print magazine, connects project owners with investors, financiers and solution providers around opportunities that require capital, partnerships and support to move towards implementation.

Submit a project to the Project & Investment Network (https://apo-opa.co/4e0ia0n)

Continuing the water security conversation

The next Water Security & Infrastructure Volume 2027 will continue examining the infrastructure, policy, technology and investment decisions affecting the sector.

The volume’s content is relevant to public and private stakeholders because water risk cuts across municipal services, agriculture, mining, manufacturing, data infrastructure, public health and wider economic development.

Future progress will depend on linking resource management with accountable operations, viable projects and the capital required to deliver them.

Join the Water Security & Infrastructure Volume 2027 waiting list (https://apo-opa.co/3TFdPcb)

Distributed by APO Group on behalf of VUKA Group.

 




 

Continue Reading

Business

Harvestfield Strengthens Nigeria’s Healthcare Manufacturing Capacity with Local Production of Next-Generation Mosquito Nets

Published

on

Harvestfield

Operations at the company’s manufacturing facility in the Harvestfield Free Trade Zone, Ogun State, commenced on 13 September 2026, with the facility already supplying a World Bank-funded programme reaching 31 states

LAGOS, Nigeria, September 30, 2026/APO Group/ –Harvestfield Healthcare FZE (www.HarvestfieldHealthcare.com) has commenced commercial production of Synera DuoForte, a next-generation insecticide-treated nets in Nigeria, marking a new phase in the country’s capacity to manufacture a critical malaria prevention intervention locally.

 




  

Operations at the company’s manufacturing facility in the Harvestfield Free Trade Zone, Ogun State, commenced on 13 September 2026, with the facility already supplying a World Bank-funded programme reaching 31 states.

The facility is the first of its kind in Nigeria to be wholly Nigerian-owned and manufactures dual active ingredient long-lasting insecticidal nets of the pyrethroid-chlorfenapyr class. Harvestfield manufactures the nets under a manufacturing agreement with GDM Health Products, producing Synera DuoForte, a dual active ingredient long-lasting insecticidal net developed and owned by GDM.

Unlike conventional insecticide-treated nets that rely primarily on pyrethroids, these nets combine a pyrethroid with a second insecticide that works through a different mode of action.

The distinction is significant as mosquito populations across much of Nigeria have developed resistance to pyrethroid insecticides. While conventional nets can continue to provide a physical barrier, resistance can reduce their insecticidal effect. Dual active ingredient nets are designed to remain effective in areas where pyrethroid resistance has taken hold, and the World Health Organisation recommends this class of net for areas with established pyrethroid resistance.

Synera DuoForte is a WHO-prequalified product, developed and held under prequalification by GDM Health Products. The Harvestfield manufacturing site in Ogun State is also included as an approved manufacturing location under that prequalification, and the facility is separately certified by the National Agency for Food and Drug Administration and Control (NAFDAC) and ISO certified. These standards provide the foundation for manufacturing nets for national malaria programmes and other health interventions requiring internationally recognised quality systems.

Jon Bastow, a representative of GDM Health Products, said: “GDM is pleased to strategically partner with Harvestfield to bring Synera DuoForte to Nigeria, the country with the biggest global malaria burden, and support the prequalification of Harvestfield’s Ogun State manufacturing facility to make Synera DuoForte.”

Building the capacity to manufacture our own health products is central to Nigeria’s health security

Commenting on the development, the Coordinating Minister of Health and Social Welfare, Professor Muhammad Ali Pate, said:

“Building the capacity to manufacture our own health products is central to Nigeria’s health security. A Nigeria-based facility producing next-generation insecticide-treated nets to international standard, and already supplying programmes across thirty-one states, is the kind of capability the Renewed Hope agenda was created to build.”

For Harvestfield, the move into manufacturing builds on more than two decades of experience in Nigeria’s vector control sector. The Harvestfield group has operated in Nigerian vector control for 26 years, delivering more than 42 million insecticide-treated nets across all 36 states and serving as an exclusive national distribution partner for WHO-prequalified nets since 2018.

The transition from distribution to manufacturing also strengthens the domestic supply chain for insecticide-treated nets. Producing locally reduces dependence on overseas supply schedules and the 45 to 60-day ocean journey associated with imported nets, while creating greater capacity to respond as malaria control needs and insecticide resistance patterns evolve.

Commenting on the role of local manufacturing in strengthening Nigeria’s healthcare value chain, Dr Abdul Mukhtar, Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC), said:

“PVAC exists to move Nigeria from importing its health products to making them. What matters is not only that a factory exists, but that it meets the standards international buyers accept and can supply at national scale. A facility based in Nigeria doing both is precisely the outcome this initiative was created to unlock.”

The investment also creates local manufacturing, technical, quality and regulatory capabilities that can support the production of other health products over time. For Harvestfield, the net manufacturing facility represents the first platform in a broader effort to build healthcare manufacturing capability in Nigeria.

This development is aligned with the Federal Government’s focus on strengthening domestic production of health products under the Renewed Hope agenda for health, the Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC), and the Nigeria First procurement policy.

www.HarvestfieldHealthcare.com

Distributed by APO Group on behalf of Harvestfield Healthcare FZE.

 

 




 

Continue Reading

Health

Nigeria achieves historic milestone as Health Textiles Nigeria begins manufacture of Vestergaard’s PermaNet® Dual mosquito nets

Published

on

Nigeria

The facility is the first in Nigeria to manufacture dual-active ingredient insecticide-treated mosquito nets (ITNs)

LAGOS, Nigeria, September 10, 2026/APO Group/ –Vestergaard Sàrl (www.Vestergaard.com) announced today that Health Textiles Nigeria FZE is now operational, marking a major milestone in the fight against malaria and establishing Nigeria as a leading hub for the production of next-generation mosquito nets in Africa. At scale, Health Textiles Nigeria will produce 10 million nets per year, employing more than 600 people in Nigeria.

The facility is the first in Nigeria to manufacture dual-active ingredient insecticide-treated mosquito nets (ITNs). It will produce PermaNet® Dual – Vestergaard’s most advanced net designed to combat insecticide resistance, which was prequalified by the World Health Organization (WHO) in 2023. Health Textiles Nigeria has been acknowledged by WHO as a Vestergaard production site.

 




  

As operations scale up, Health Textiles Nigeria represents a significant step forward in expanding access to one of the most effective tools available for malaria prevention. Support from the Government of Nigeria has been instrumental, symbolizing a shared commitment to strengthening malaria prevention through local initiatives.

 

Dr Muhammad Ali Pate, Coordinating Minister of Health and Social Welfare in Nigeria, said: “The commencement of local production of next-generation insecticide-treated nets is an important milestone for Nigeria’s health system and our fight against malaria. It also reflects our broader commitment to strengthening health security by building domestic capacity to manufacture the essential health products Nigerians need. Through partnerships that bring together global expertise, Nigerian talent and local production, we are building a more resilient healthcare value chain while creating skilled jobs and positioning Nigeria as a competitive manufacturing hub for Africa.”

 

This progress comes at a pivotal time in the global fight against malaria. Since 2000, ITNs including PermaNet Dual have been responsible for averting 1.13 billion cases (https://apo-opa.co/4ir1imJ). Yet malaria remains a significant  global health threat, particularly for women and young children, with an estimated 282 million cases and 610,000 deaths (https://apo-opa.co/4cAniHX) recorded by WHO globally in 2024. Africa remains hardest hit by malaria, and Nigeria accounts for a quarter of the world’s cases.

 

Health Textiles Nigeria (https://apo-opa.co/4xXcrjV) responds to this urgent need by expanding local capacity and expertise to produce life-saving malaria prevention tools, fulfilling the vision set out in a Memorandum of Understanding (MOU) signed in 2024 between Vestergaard and the Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC). The agreement, which focuses on strengthening local production capacity, establishes Nigeria as West Africa’s first manufacturing hub for dual active-ingredient mosquito nets.

 

Today we welcome the start of a new chapter in Africa’s fight against malaria

Dr Abdu Mukhtar, National Coordinator of PVAC, said: “This milestone demonstrates what is possible when investment, technology transfer and government policy are deliberately aligned to build local manufacturing capability. When PVAC and Vestergaard signed the MOU in 2024, the objective was not simply to attract investment, but to translate partnership into productive capacity in Nigeria. Seeing Nigerian professionals trained, production underway and a pathway established to manufacture at scale is exactly the kind of outcome we want to replicate across the healthcare value chain.”

 

Health Textiles Nigeria is wholly owned by Vestergaard, a global leader in malaria prevention that has supplied approximately one-third of all insecticide-treated nets publicly procured worldwide since 2000. The company brings decades of manufacturing expertise, rigorous quality assurance systems and a proven track record in developing and scaling innovative vector-control technologies that have helped protect millions of people from malaria.

 

Amar Ali, CEO of Vestergaard, said: “Today we welcome the start of a new chapter in Africa’s fight against malaria, and we thank Minister Pate for his leadership and the unwavering support of the Nigerian government. By combining Nigerian talent with world-class manufacturing and Vestergaard’s deep expertise in innovative malaria prevention tools, Health Textiles Nigeria will deliver the highest standards of quality, compliance and performance. We believe this facility can become a benchmark for malaria prevention manufacturing in Africa and help ensure that life-saving mosquito nets are produced closer to the communities that need them most.”

 

Health Textiles Nigeria is placing quality, training and compliance at the heart of its operations. The company has already recruited around 80 employees, with rigorous training covering manufacturing excellence, product quality, health and safety, and regulatory compliance ongoing. As production expands, the facility is expected to create additional employment opportunities while developing a highly skilled workforce capable of supporting world-class health-product manufacturing.

 

The facility builds on Vestergaard’s decades of commitment to innovation, quality, and delivering practical solutions for malaria prevention. Every aspect of production is designed to meet the company’s stringent global standards, ensuring that PermaNet Dual manufactured in Nigeria delivers the performance, reliability and quality that health programmes around the world depend on.

 

As countries across Africa increasingly prioritize local manufacturing of essential health products, Health Textiles Nigeria demonstrates how international expertise and local capability can combine to strengthen supply chains, create skilled jobs and improve access to critical health interventions.

 

With production now underway, the first commercial orders are expected to be fulfilled in the coming months.

Distributed by APO Group on behalf of Vestergaard Sàrl.

 

 




 

Continue Reading

Trending